SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN E.DAGGS who wrote (2494)2/3/1999 3:17:00 PM
From: BWAC  Read Replies (1) of 2553
 
Sorry to hear that. I guess the perception depends greatly on your entrance point. I originally bought some at 4 5/16. And then bought a whole lot at 2 1/4. Throw in a few daytrades and my average is about $1.

So things look good to me. I know the carticel product works well as my wife works as a therapist and has had a patient come through the clinic she works in. As GENZL works on the insurance companies for Carticel reimbursement and they get rid of some of the Diacrin expense things should begin to look up. In the last conference call they strongly implied they were looking at 6 quarters months until profitability at the current growth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News